A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease has been linked to a one-third higher risk of cardiovascular-related deaths. The drug is ipratropium. A new study found that veterans with recently diagnosed COPD using ipratropium were 34 percent more likely to die of a heart attack or of arrhythmia.